Loading market data...
Friday, August 14, 2026
Back to HomeKorea StockPremium

Cosmo Advanced Materials (005070.KS) Q1 2026: Net Loss as ₩3B Interest Bill Eclipses Operating Profit, ₩120B CB Bets on Europe

Share
Cosmo Advanced Materials (005070.KS) Q1 2026: Net Loss as ₩3B Interest Bill Eclipses Operating Profit, ₩120B CB Bets on Europe

Cosmo Advanced Materials (005070.KS) Q1 2026: Net Loss as ₩3B Interest Bill Eclipses Operating Profit, ₩120B CB Bets on Europe

Revenue recovers 7.8% year-on-year but a ₩3.0 billion interest burden runs nearly three and a half times the entire operating profit, exposing the structural gap between Cosmo's financing ambitions and its current earnings capacity.

Source: Q1 2026 Quarterly Report (분기보고서) — Filed May 2026 with DART | Standalone Financial Statements (K-IFRS) | Unit: ₩ billions

Unlimited U.S.-market analysis, $9.99/month

Cosmo Advanced Materials (005070.KS) Q1 2026: Net Loss as ₩3B Interest Bill Eclipses Operating Profit, ₩120B CB Bets on Europe

This article became available on July 16, 2026. Subscribe to read in full, or wait until October 14, 2026 when it becomes free.

Cancel anytime. Full refund within 7 days.

Access is tied to your account. Subscribe with the same email you sign up with — if you already paid, sign up with that email and it unlocks automatically.

NewsFinanceMarkets

Go deeper than the headline

You just read what happened. Here's how to read what it means.

Free daily briefing

The U.S. market, every morning — free

LineVest Daily lands in your inbox before every opening bell: the key U.S. markets stories, earnings, disclosures and foreign flows — in plain English. Free, no card required.

Get LineVest Daily — free →
This company

Full report on Cosmo Advanced Materials

We read Cosmo Advanced Materials's latest SEC filing in full — financials under US GAAP, governance, and what it means for the stock. PDF in your inbox within 3 hours.

$12 · one-time

Get the Cosmo Advanced Materials report
Every name you watch

Follow the whole market

Reading several U.S. stocks a week? Read every analysis article the moment it publishes — full daily U.S. market coverage plus the 90-day archive.

$9.99 · monthly

Subscribe

Independent journalism based on primary SEC filings — not investment advice. No brokerage affiliation.